期刊文献+

经手术切除的原发性小肝癌患者复发的危险因素分析 被引量:8

下载PDF
导出
摘要 目的分析经手术切除的原发性小肝癌患者的复发影响因素,为临床诊治提供参考。方法选取2008年6月—2010年6月54例在我科经手术治疗的小肝癌患者进行回归性分析,入选患者均具有完整的临床病理资料,平均随访27.2个月,以肿瘤复发或转移作为终点事件,通过单因素及Cox回归模型多因素分析影响预后复发的危险因素。结果 48例患者获得随访截至至今,3例患者失访,随访率为94.1%。10例患者死亡,27例复发或转移,肝内复发21例,4例肝内复发伴肺转移,1例脑转移,1例骨转移,术后总体(overall survival,OS)生存时间为5~71个月,中位OS时间为30个月,1、3年总体生存率为97.2%、82.1%;无瘤(disease free survival,DFS)生存时间为2~73个月,中位DFS时间为24个月,1、3年无瘤生存时间为70.2%、54.2%。将19项因素分别纳入单因素及COX多因素分析,结果提示门脉癌栓,肿瘤直径超过3 cm,肿瘤多发,术中输血超过600 mL是影响小肝癌患者术后无瘤生存时间的危险因素(P〈0.05)。结论小肝癌切除术后患者预后较好,无瘤生存时间受门脉癌栓,肿瘤直径超过3 cm,肿瘤多发,术中输血超过600 mL等因素影响。
作者 苏瑛 龚昭
出处 《安徽医药》 CAS 2014年第7期1306-1308,共3页 Anhui Medical and Pharmaceutical Journal
  • 相关文献

参考文献9

二级参考文献63

共引文献117

同被引文献86

  • 1Sposito C,Mariani L,Germini A,et al. Comparative effi-cacy of sorafenib versus best supportive care in recurrenthepatocellular carcinoma after liver transplantation: Acase-control study [J]. Journal of Hepatology ,2013,59(1):59-66.
  • 2Torzilli G, Donadon M,Cimino M. Are tumor exposure andanatomical resection antithetical during surgery for hepa-tocellular carcinoma? A critical review [J]. Liver Cancer,2012,1(34):177-182.
  • 3Ash S A,Buggy D J. Does regional anaesthesia and anal-gesia or opioid analgesia influence recurrence after primarycancer surgery? An update of available evidence[J]. BestPractice & Research Clinical Anaesthesiology, 2013,27(4):441-456.
  • 4McCarter M D,Antonescu C R,Ballman K V,et al. Mi-croscopically positive margins for primary gastrointestinalstromal tumors: Analysis of risk factors and tumor recur-rence[J]. Journal of the American College of Surgeons,2012,215(1):53-59.
  • 5Vigan6 L,Capussotti L,Lapointe R,et al Early recur-rence after liver resection for colorectal metastases: Riskfactors, prognosis and treatment.A Liver Met Survey -based study of 6,025 patients [J]. Annals of Surgical On-cology,2014,21(4) : 1276-1286.
  • 6Li T,Fan J,Qin L X,et al. Risk factors, prognosis andmanagement of early and late intrahepatic recurrence afterresection of primary clear cell carcinoma of the liver [J],Annals of Surgical Oncology,2011,18(7) : 1955-1963.
  • 7Li J J, Zheng JS, Cui SC, et al. C - arm Lipiodol CT in transeatheter arterial chemoembolization for small hepatocellular carcinoma [ J ]. World J Gastroenterol,2015,21 (10) : 3035 - 3040.
  • 8Xu RH, Gao W, Wang C, et al. Retraction Note : Systematic evalua-tion of percutaneous radiofrequency ablation versus percutaneous ethanol injection for the treatment of small hepatocellular carcino- ma: a meta - analysis [ J ]. Eur J Med Res, 2015,20 ( 1 ) :41 - 46.
  • 9Hefaiedh R, Sabbegh M, Ennaifer R, et al. Percutaneous treatment versus hepatic resection for the treatment of small hepatocellular carcinoma[J].Tunis ned ,2014,92 ( 12 ) :711 - 716.
  • 10Feng K, Yan J, Li X, et al. A randomized controlled trial of radio- frequency ablation and surgical resection in the treatment of small hepatocellular carcinoma[ J ]. J Hepato1,2012,57 (4) :794 - 802.

引证文献8

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部